GPN01530-2 Granted Fast Track Designation By FDA
09/08/2026 11:11
BRIEF-Grand Pharmaceutical Group - GPN01530-2 Granted Fast Track Designation By FDA Aug 9 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK:
GRAND PHARMACEUTICAL GROUP - INDEPENDENTLY DEVELOPED, GLOBALLY INNOVATIVE RADIONUCLIDE-DRUG CONJUGATE, GPN01530-2, GRANTED FAST TRACK DESIGNATION BY THE FDA
Further company coverage: 0512.HK
(Reporting by Beijing Newsroom)
((Shi.Bu@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement